BMAL1 and Alzheimer disease: Studies have found that Bmal1−/− mice lose circadian rhythmicity at the behavioural and molecular levels,6 and the triple‐transgenic AD mouse model exhibits Aβ deposition in the brain and abnormal expression of Bmal1.7